The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Optimal positioning of liquid biopsies in the workup of patients with NSCLC
Umberto Malapelle, PhD, University of Naples Federico II, Naples, Italy, discusses precision oncology beyond EGFR/ALK in non-small cell lung cancer (NSCLC), where he sheds light on the optimal positioning of liquid biopsies in the workup of patients with NSCLC, touching on practical considerations in the use of liquid biopsies. This interview took place at the European Lung Cancer Congress 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
